TRACK RECORD

46 years' experience
PR-it member since 2021

COLLECTIVE

Shari - Investor Relations

Shari has provided investor relations counsel to C-suite clients in the life sciences and financial services industries in the US, Europe and Japan. Her sweet spot is taking a company from late-stage private to public, and bringing undiscovered public companies to Wall Street’s attention.

With a hands-on approach that focuses on crafting and executing communications strategies, Shari helps management teams to attract new investment by providing insight into how investors think about companies as they mature from venture to public arenas.

With a cross-section of experience in corporate management, investment banking and public relations, Shari can support with materials development, presentation training, market surveillance and relationship-building. Shari’s long-standing relationships with investors across the US and Europe uniquely position her to provide counsel and support for initial public offerings and fundraising rounds, especially series C and crossover.

After beginning her career as a White House intern, Shari joined the US Senate Commerce Committee and later became a national and state lobbyist. She began her career in investor relations at global agency, Burson-Marsteller, worked internally at several life science firms and a boutique investment bank before becoming an independent expert.

Shari holds a BA in psychology from the University of Pennsylvania and studied in Stanford and Columbia graduate business programs.

TRACK RECORD

46 years' experience
PR-it member since 2021

BRAND EXPERIENCE

  • Freelance investor relations for GlycoMimetics
  • Freelance investor relations for Tizona
  • Freelance investor relations for Symphogen
  • Freelance investor relations for Oncomed Pharmaceuticals
  • Freelance investor relations for Calithera
  • Freelance investor relations for Immune Design
  • Freelance investor relations for InspireMD
  • Freelance investor relations for Iconic Therapeutics
  • Freelance investor relations for Relypsa
  • Freelance investor relations for Dynavax